Global Investigative Journalism Network

3 posts

Reporting Tools & Tips

Lessons from the Pandemic: COVID-19 and Health-Pharma Investigations

by Laura Oliver • November 10, 2021

During the COVID-19 pandemic, journalists worldwide were suddenly thrown into the public health beat, trying to make sense of competing claims, and a science that seemed to change by the day. A session at the GIJC21 walked reporters through the COVID-19 pandemic, offering tips on covering the drug development and approval processes, evaluating scientific studies, unearthing conflicts of interest, and exposing fraud and malpractice.

Data Journalism

Data Journalism Top 10: A New President, Trump’s Twitter Insults, Germany’s Elections, Flying Green

by Peter Georgiev and Connected Action • January 29, 2021

As Joe Biden was sworn in as the 46th president of the United States, much of the international media coverage was focused on an inauguration like no other. Our NodeXL #ddj mapping from January 18 to 24 found a Washington Post analysis of the president’s first address to the nation and a Bloomberg project visualizing the enhanced measures put in place to deal with concerns about security and the coronavirus.

News & Analysis

Document of the Day: A Look at Pfizer’s Vaccine Press Release

by Rowan Philp • December 1, 2020

A November 18 press release, claiming a safe vaccine that protects 95% of people against COVID-19, by pharmaceutical companies Pfizer and BioNTech was greeted with excited headlines. In this article, two leading health reporters shared tips on how to read such releases and balanced cautious optimism with the provision that the release relied on interim results from a trial in an accelerated setting.

Accessibility Settings

text size

color options

reading tools

other

Tag